Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Gray

Showing results (1101-1110 of 1,555) with videos related to

Pageof 156
Sort By:
Cell Chemical Biology|August 11, 2023
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligaseYounghoon Kim, Pooreum Seo, Eunhye Jeon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine productionG J Freeman, D B Lombard, C D Gimmi, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|May 15, 1998
Ixodes ricinus strains in EuropeA Estrada-Peña, M Daniel, F Frandsen, et al.
Plos One|June 14, 2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerAmit Dutt, Alex H Ramos, Peter S Hammerman, et al.
European Journal of Medicinal Chemistry|May 22, 2017
Discovery of a potent dual ALK and EGFR T790M inhibitorJaebong Jang, Jung Beom Son, Ciric To, et al.
Cell|July 16, 2018
Structure of the Human cGAS-DNA Complex Reveals Enhanced Control of Immune SurveillanceWen Zhou, Aaron T Whiteley, Carina C de Oliveira Mann, et al.
Science (New York, N.Y.)|July 27, 2013
mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycinSeong A Kang, Michael E Pacold, Christopher L Cervantes, et al.
Oncotarget|February 6, 2019
Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studiesAshleigh C McEvoy, Michelle R Pereira, Anna Reid, et al.
Cancer Research|July 30, 2017
Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung AdenocarcinomaYan Liu, Yuyang Li, Xiaoen Wang, et al.
Angewandte Chemie (International Ed. in English)|April 29, 2021
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2Guangyan Du, Jie Jiang, Qibiao Wu, et al.
Pageof 156

Showing results (1101-1110 of 1,555) with videos related to

Sort By:
Pageof 156
Cell Chemical Biology|August 11, 2023
Targeted kinase degradation via the KLHDC2 ubiquitin E3 ligaseYounghoon Kim, Pooreum Seo, Eunhye Jeon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1992
CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine productionG J Freeman, D B Lombard, C D Gimmi, et al.
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|May 15, 1998
Ixodes ricinus strains in EuropeA Estrada-Peña, M Daniel, F Frandsen, et al.
Plos One|June 14, 2011
Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancerAmit Dutt, Alex H Ramos, Peter S Hammerman, et al.
European Journal of Medicinal Chemistry|May 22, 2017
Discovery of a potent dual ALK and EGFR T790M inhibitorJaebong Jang, Jung Beom Son, Ciric To, et al.
Cell|July 16, 2018
Structure of the Human cGAS-DNA Complex Reveals Enhanced Control of Immune SurveillanceWen Zhou, Aaron T Whiteley, Carina C de Oliveira Mann, et al.
Science (New York, N.Y.)|July 27, 2013
mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycinSeong A Kang, Michael E Pacold, Christopher L Cervantes, et al.
Oncotarget|February 6, 2019
Monitoring melanoma recurrence with circulating tumor DNA: a proof of concept from three case studiesAshleigh C McEvoy, Michelle R Pereira, Anna Reid, et al.
Cancer Research|July 30, 2017
Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung AdenocarcinomaYan Liu, Yuyang Li, Xiaoen Wang, et al.
Angewandte Chemie (International Ed. in English)|April 29, 2021
Discovery of a Potent Degrader for Fibroblast Growth Factor Receptor 1/2Guangyan Du, Jie Jiang, Qibiao Wu, et al.
Pageof 156